Quick Answer
Acumen Pharmaceuticals, Inc. reported Total Assets of $122.83 million for fiscal year 2025.
Acumen Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $122.83M | -48.6% |
| 2024 | $238.99M | -22.9% |
| 2023 | $310.12M | +57.8% |
| 2022 | $196.59M | -14.6% |
| 2021 | $230.33M | +418.4% |
| 2020 | $44.43M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $142.22M | -46.7% | -17.3% |
| June 30, 2025 | $171.90M | -40.5% | -15.9% |
| March 31, 2025 | $204.48M | -32.1% | -14.4% |
| December 31, 2024 | $238.99M | -22.9% | -10.5% |
| September 30, 2024 | $266.98M | -6.8% | -7.6% |
| June 30, 2024 | $288.91M | +62.9% | -4.0% |
| March 31, 2024 | $300.97M | +60.2% | -3.0% |
| December 31, 2023 | $310.12M | +57.8% | +8.3% |
- Acumen Pharmaceuticals, Inc. showed a decrease of -48.6% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Acumen Pharmaceuticals, Inc.’s total assets has grown by 176.5% (from $44.43 million to $122.83 million).
- The most recent figure is from Acumen Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: